
NYSE:ULS
This summary was created by AI, based on 1 opinions in the last 12 months.
UL Solutions (ULS-N) engages in vital product testing services that, while sometimes overlooked, play a crucial role in the manufacturing and safety sectors. The recent trend of on-shoring has resulted in increased domestic production, creating a corresponding rise in demand for rigorous testing services. Analysts recognize this growing need and anticipate continued growth for UL Solutions in the coming years. With a balanced perspective, experts have given a rating of 'Buy' from 7 analysts, 'Hold' from 4, and 'Sell' from 1, suggesting a strong overall confidence in the company's future. The average analyst price target of $71.19 further indicates a favorable outlook for investors considering this stock.
UL Solutions is a American stock, trading under the symbol ULS (previously ULS-N on Stockchase) on the New York Stock Exchange (ULS). It is usually referred to as NYSE:ULS or ULS
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on ULS (previously ULS-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for UL Solutions .
UL Solutions was recommended as a Top Pick by Brendan Caldwell on 2025-09-22. Read the latest stock experts ratings for UL Solutions .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for UL Solutions .
UL Solutions is covered by Stockchase experts and is worth watching.
On 2026-08-12, UL Solutions (ULS) stock closed at a price of $76.68.
It does product testing which could be considered boring but is also necessary and has its place. There are two themes: on-shoring and outsourcing. With more products being made in the US because of on-shoring there is more demand for testing of these products so we should continue to see growth. Nobody has been really looking at it so that could be of benefit. Buy 7 Hold 4 Sell 1
(Analysts’ price target is $71.19)